Results 201 to 210 of about 25,505 (239)

The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases. [PDF]

Biology (Basel)
Danna R, Kondle S, Amar O, Mabourakh M, Chen G, Fadol WB, Mohieldin AM.   +6 more
europepmc   +1 more source

The clinical phenotype of carriers of intermediate alleles in the huntingtin gene: A scoping review. [PDF]

J Huntingtons Dis
van Hofslot A, Oosterloo M, de Jong JJA, Andriessen RL, de Bot ST, Linden DEJ.   +5 more
europepmc   +1 more source

FibrilPaints for visualisation and ubiquitination of Huntingtin amyloid fibrils

Dekker FA, van Weert E, Mayer G, Garfagnini T, Pedrola JA, Vertegaal AC, Friedler A, Rüdiger SGD.   +7 more
europepmc   +1 more source

Movement disorders: a brief overview from an evolutionary perspective. [PDF]

J Neural Transm (Vienna)
Garcia Ruiz PJ.
europepmc   +1 more source

Late-Onset Huntington's Disease: A Case Report and Literature Review. [PDF]

Cureus
Gonçalves C, Ferreira AS, Calheiros A, Lopes Freitas R, Cacao G.   +4 more
europepmc   +1 more source

Correction to: Toxic effects of mutant huntingtin in axons are mediated by its proline-rich domain. [PDF]

Brain
europepmc   +1 more source

From genes to trajectories: mapping genetic influences on Huntington's disease progression. [PDF]

Bioinformatics
Dey S, Sun Z, Warner J, Koski E, Eyigoz E, Sathe S, Sampaio C, Hu J.   +7 more
europepmc   +1 more source

<i>cnnm-5</i> knockdown improves proteostasis of mutant Huntingtin protein in <i>C. elegans</i>. [PDF]

MicroPubl Biol
Hull M, Mills J.
europepmc   +1 more source

Luteolin and neuroinflammation: a multi-target therapeutic strategy for central nervous system disorders. [PDF]

Front Pharmacol
Huang J, Yu M, Zou Y, Wang L, Ma Y, Ma Y, Kong X, Rong F.   +7 more
europepmc   +1 more source